Farallon Capital Management’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Hold |
750,000
| – | – | 0.01% | 80 |
|
|
2025
Q1 | $1.49M | Hold |
750,000
| – | – | 0.01% | 82 |
|
|
2024
Q4 | $2.19M | Hold |
750,000
| – | – | 0.01% | 87 |
|
|
2024
Q3 | $2.9M | Hold |
750,000
| – | – | 0.01% | 93 |
|
|
2024
Q2 | $3.86M | Hold |
750,000
| – | – | 0.02% | 89 |
|
|
2024
Q1 | $5.25M | Buy |
+750,000
| New | +$5.25M | 0.02% | 97 |
|